Compare Medtronic PLC (MDT) vs 3M Company (MMM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs 3M Company — how do they compare? Medtronic PLC trades at $82.68 (market cap $106.61B), while 3M Company trades at $173.16 (market cap $82.99B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| MDT | MMM | |
|---|---|---|
Market Cap | $106.61B | $82.99B |
Sector | Health | Industrials |
52-Week High | $105.35 | $174.61 |
52-Week Low | $73.75 | $141.10 |
Enterprise Value | $125.36B | $91.39B |
Dividend Yield | 3.46% | 1.96% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
3M (MMM) trades at $159.98, up 0.09% on the day, with a bullish technical signal from moving averages and recent earnings beats. The company reported Q1 2026 EPS of $2.14, exceeding the $1.98 estimate, and maintains a strong net income margin of 11.14%. Analysts are divided with a 48.49% buy rating, and the consensus price target is $149.75. Recent news highlights Q2 earnings expectations and new partnerships, such as the Airbus A220 supply agreement.
The outlook for MMM is mixed; earnings momentum and cost optimization support growth, but valuation ratios like a P/E of 30.8 suggest premium pricing. Risks include consumer segment weakness and debt levels. Upside depends on Q2 results meeting the $2.27 EPS forecast, while downside could stem from macroeconomic pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →
